| Julian Rayner | |
| Birth Name: | Julian Charles Rayner |
| Workplaces: | Wellcome Sanger Institute Laboratory of Molecular Biology Centers for Disease Control and Prevention University of Alabama at Birmingham University of Cambridge |
| Alma Mater: | University of Cambridge (PhD) |
| Thesis Title: | Sorting of membrane proteins in the yeast secretory pathway |
| Thesis Url: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.627276 |
| Thesis Year: | 1997 |
| Doctoral Advisors: | )--> |
| Spouses: | )--> |
| Partners: | )--> |
Julian Charles Rayner is a New Zealand malaria researcher, and the Director of the Cambridge Institute for Medical Research, part of the University of Cambridge School of Clinical Medicine. He is also Director of Wellcome Connecting Science. He was previously a member of academic Faculty at the Wellcome Sanger Institute.
Julian Rayner became Director of CIMR in 2019.
Rayner was born in New Zealand,[1] [2] and completed his undergraduate studies at Lincoln University,[3] before undertaking his PhD at the University of Cambridge.[4] His doctoral research investigated the sorting of membrane proteins in the yeast secretory pathway while based at the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) in Cambridge.[4]
Rayner joined the Sanger Institute in 2008,and became a Senior Group Leader in 2013.[5] In 2014 he was appointed as the Director of Connecting Science for the Wellcome Genome Campus.[6]
In 2019, he joined the University of Cambridge, as the Director of the Cambridge Institute for Medical Research.[7] He was also elected to the Chair of Cell Biology in the School of Clinical Medicine.[8]
Rayner's research interests encompass the origins of Plasmodium parasites, and how their invasion of red blood cells cause all the symptoms of malaria. Working with collaborators such as Beatrice Hahn, he has demonstrated that Plasmodium falciparum is likely to have originated in gorillas, rather than chimpanzees or ancient humans.[9] Together with colleagues at the Sanger Institute, Rayner has identified a key ligand which is essential for erythrocyte invasion by P. falciparum and therefore has significant anti-malarial potential.[10]
In March 2011 Rayner took part in the Argon Zone of the science engagement activity I'm a Scientist, Get me out of here!, where he won £500 to put towards a science communication project.[11] Rayner used the prize money to create compact disc versions of the interactive game Malaria Challenge[12] and distributed copies freely to schools in the UK.[13]
In 2015 he was awarded CA Wright Memorial medal by the British Society for Parasitology.[14]
In 2022 Rayner was elected as a Fellow of EMBO, the European Molecular Biology Organization. [15]
In 2023 Rayner was elected to the Fellowship of the Academy of Medical Sciences in the UK.[16]